Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charles-Antoine Guay

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Open Forum Infectious Diseases|June 29, 2026
Influenza Vaccines for Persons Who Are Immunocompromised: A Scoping Review of the LiteratureCharles-Antoine Guay, Brendan Flannery, Manish Patel
Clinical Lung Cancer|September 9, 2025
The Changing Landscape of Lung Cancer Resection Outcomes Over the Past two DecadesCharles-Antoine Guay, Alexandre Suhani, Laurie Perreault, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 11, 2023
Influenza Hospitalization Burden by Subtype, Age, Comorbidity, and Vaccination Status: 2012-2013 to 2018-2019 Seasons, Quebec, CanadaSara Carazo, Charles-Antoine Guay, Danuta M Skowronski, et al.
Plos One|October 12, 2018
Pulmonary hypertension-targeted therapies in heart failure: A systematic review and meta-analysisCharles-Antoine Guay, Louis-Vincent Morin-Thibault, Sebastien Bonnet, et al.
Chest|June 9, 2019
Extended Anticoagulation for VTE: A Systematic Review and Meta-AnalysisVicky Mai, Charles-Antoine Guay, Laurie Perreault, et al.
BMC Pulmonary Medicine|September 13, 2024
Trends in COPD severe exacerbations, and all-cause and respiratory mortality, before and after implementation of newer long-acting bronchodilators in a large population-based cohortCharles-Antoine Guay, François Maltais, Claudia Beaudoin, et al.
Chest|November 28, 2017
Trial Duration and Risk Reduction in Combination Therapy Trials for Pulmonary Arterial Hypertension: A Systematic ReviewAnnie C Lajoie, Charles-Antoine Guay, Jean-Christophe Lega, et al.
BMJ Open Respiratory Research|August 28, 2025
Prognostic impacts of interstitial lung abnormalities on outcomes following resection for lung cancerCharles-Antoine Guay, Pierre-Emile Charest, Frederic-Thomas Caron, et al.
Lancet Regional Health. Americas|March 19, 2026
Nirsevimab effectiveness, number needed to immunize and impact on severe RSV outcomes, a test-negative study in Quebec, CanadaSara Carazo, Manale Ouakki, Danuta M Skowronski, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 29, 2025
Effectiveness of COVID-19 vaccination and prior infections to reduce long COVID risk during the pre-Omicron and Omicron periodsSara Carazo, Jonathan Phimmasone, Danuta M Skowronski, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Open Forum Infectious Diseases|June 29, 2026
Influenza Vaccines for Persons Who Are Immunocompromised: A Scoping Review of the LiteratureCharles-Antoine Guay, Brendan Flannery, Manish Patel
Clinical Lung Cancer|September 9, 2025
The Changing Landscape of Lung Cancer Resection Outcomes Over the Past two DecadesCharles-Antoine Guay, Alexandre Suhani, Laurie Perreault, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 11, 2023
Influenza Hospitalization Burden by Subtype, Age, Comorbidity, and Vaccination Status: 2012-2013 to 2018-2019 Seasons, Quebec, CanadaSara Carazo, Charles-Antoine Guay, Danuta M Skowronski, et al.
Plos One|October 12, 2018
Pulmonary hypertension-targeted therapies in heart failure: A systematic review and meta-analysisCharles-Antoine Guay, Louis-Vincent Morin-Thibault, Sebastien Bonnet, et al.
Chest|June 9, 2019
Extended Anticoagulation for VTE: A Systematic Review and Meta-AnalysisVicky Mai, Charles-Antoine Guay, Laurie Perreault, et al.
BMC Pulmonary Medicine|September 13, 2024
Trends in COPD severe exacerbations, and all-cause and respiratory mortality, before and after implementation of newer long-acting bronchodilators in a large population-based cohortCharles-Antoine Guay, François Maltais, Claudia Beaudoin, et al.
Chest|November 28, 2017
Trial Duration and Risk Reduction in Combination Therapy Trials for Pulmonary Arterial Hypertension: A Systematic ReviewAnnie C Lajoie, Charles-Antoine Guay, Jean-Christophe Lega, et al.
BMJ Open Respiratory Research|August 28, 2025
Prognostic impacts of interstitial lung abnormalities on outcomes following resection for lung cancerCharles-Antoine Guay, Pierre-Emile Charest, Frederic-Thomas Caron, et al.
Lancet Regional Health. Americas|March 19, 2026
Nirsevimab effectiveness, number needed to immunize and impact on severe RSV outcomes, a test-negative study in Quebec, CanadaSara Carazo, Manale Ouakki, Danuta M Skowronski, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 29, 2025
Effectiveness of COVID-19 vaccination and prior infections to reduce long COVID risk during the pre-Omicron and Omicron periodsSara Carazo, Jonathan Phimmasone, Danuta M Skowronski, et al.
Pageof 2